Related Experiment Video
Updated: Feb 6, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
RETRACTED: GATA4 inhibits cell differentiation and proliferation in pancreatic cancer
Yan Gong1, Liang Zhang2, Aiqun Zhang2
1Health Management Institute, Chinese PLA General ospital, Beijing, China.
Abstract:
Pancreatic ductal carcinoma (PDAC) is a common malignant tumor of the digestive system. GATA4 is one of the transcriptional regulatory factors, which regulates the development of endoderm-derived organs, including heart and gut. GATA4 may act as a putative tumor suppressor gene. However, the role of GATA4 in pancreatic carcinogenesis is not yet clarified. This study showed that GATA4 was highly expressed in pancreatic cancer tissues, and its expression level was positively related to the grade of pathological differentiation, suggesting that it may contribute to the progression of pancreatic neoplasia. Ectopic expression of GATA4 gene reduced cell viability and interference of GATA4 expression significantly increased the colony formation ability of pancreatic cancer cells. Furthermore, GATA4 inhibited tumor growth in xenograft mice. Agilent expression microarray profiling analysis indicated that the genes with significant levels of differential expression in GATA4 over-expressing cells were enriched in the cell differentiation process. Analysis of KEGG signaling pathway demonstrated that the regulated genes were partially enriched in MAPK and JAK-STAT signaling pathways. Re-expression of GATA4 up-regulated P53 gene expression. Our data indicate that GATA4 gene might play a role in cell proliferation and differentiation during the progression of pancreatic cancer.
Insights
GATA4, a gene potentially involved in tumor suppression, is highly expressed in pancreatic cancer and promotes its progression. Its manipulation affects cell viability, growth, and differentiation pathways, offering new insights into pancreatic carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic ductal carcinoma (PDAC) is a prevalent digestive system malignancy.
- GATA4, a transcription factor regulating endoderm-derived organs, has an unclear role in pancreatic cancer.
- Previous hypotheses suggested GATA4 might function as a tumor suppressor.
Purpose of the Study:
- To clarify the role of GATA4 in pancreatic carcinogenesis.
- To investigate the impact of GATA4 expression on pancreatic cancer progression and cellular behavior.
Main Methods:
- Analysis of GATA4 expression in pancreatic cancer tissues.
- In vitro studies involving ectopic GATA4 expression and gene interference in pancreatic cancer cells.
- Xenograft mouse models to assess GATA4's effect on tumor growth.
- Gene expression profiling (Agilent microarray) and pathway analysis (KEGG).
Main Results:
- GATA4 is highly expressed in pancreatic cancer tissues and correlates with higher pathological differentiation grades.
- Overexpression of GATA4 reduces pancreatic cancer cell viability and inhibits tumor growth in vivo.
- Interference with GATA4 expression enhances colony formation ability.
- Microarray analysis revealed GATA4 regulates genes involved in cell differentiation, MAPK, and JAK-STAT signaling pathways.
- GATA4 re-expression upregulates P53 gene expression.
Conclusions:
- GATA4 expression is elevated in pancreatic cancer and appears to promote tumor progression, contradicting its potential tumor suppressor role.
- GATA4 influences pancreatic cancer cell proliferation and differentiation.
- GATA4's regulatory effects involve the MAPK, JAK-STAT, and P53 pathways, highlighting its complex role in pancreatic carcinogenesis.
Related Concept Videos
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
iPS Cell Differentiation
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Enzyme Inhibition

